Parliamentary Search

Written question asked by Carla Lockhart (Democratic Unionist Party) on Wednesday, 17 June 2026, in the House of Commons. It was due for an answer on Wednesday, 24 June 2026 (named day). A holding answer was provided on Thursday, 25 June 2026. A substantive answer was provided by Preet Kaur Gill (Labour) on Monday, 29 June 2026 on behalf of the Department of Health and Social Care.

Medicines and Healthcare products Regulatory Agency: Disclosure of Information

Question

To ask the Secretary of State for Health and Social Care, with reference to the Answer of 26 March 2026 to Question 122234, what steps were taken in response to those three whistleblowing reports; and whether any procedural, governance and training changes have been implemented as a result.

Answer

The following table shows the action taken after each concern was raised, and the outcome:

Concern number

Nature of conflict of interest (COI)

Action

Outcome

Concern 1

Alleged non-declaration of a COI

Investigated (human resource procedures)

Upheld

Concern 2

Alleged non-declaration of a COI

Taken forward by management and human resources

No investigation required

Concern 3

Concern that an investigator lacked impartiality

Considered and responded to

No investigation required

The Medicines and Healthcare products Regulatory Agency’s Nominated Officers/Fraud Officers have developed a set of slides that they will present to teams later in the year to remind staff and managers of the COI procedures and why they are important, and to disseminate learning from the first two concerns.

Secondary information

Type
Written question
Reference
10760
Session
2026-27
Related items
Subjects
Disclosure of information Conflict of interests Medicines and Healthcare products Regulatory Agency
Contains statistics
Yes
Link
View this Written question on www.parliament.uk